3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Active not recruiting
3
Recruiting
2
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Glioblastoma
3
Rectal Neoplasms
2
Prostatic Neoplasms
2
Nasopharyngeal Carcinoma
2
Lung Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Esophageal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Rhabdomyosarcoma
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pathologic Complete Response
1
Oropharyngeal Neoplasms
1
Neurofibromatosis 1
1
Meningioma
1
Lymphoma
1
Glioma
1
Carcinoma, Squamous Cell
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Brain Neoplasms
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Adrenocortical Carcinoma
1
Interventions
lenvatinib
16
Bevacizumab
14
sintilimab
10
tislelizumab
9
apatinib
9
regorafenib
6
camrelizumab
6
donafenib
5
atezolizumab
5
Immune Checkpoint Inhibitors
4
Hepatectomy
4
cabozantinib
3
Radiosurgery
3
Capecitabine
3
spartalizumab
2
pembrolizumab
2
durvalumab
2
anlotinib
2
Surgical Procedures, Operative
2
Specimen Handling
2
Oxaliplatin
2
Observation
2
Magnetic Resonance Spectroscopy
2
Injections
2
Immunotherapy
2
Folfox protocol
2
Fecal Microbiota Transplantation
2
Electroporation
2
Blood Specimen Collection
2
ursodoxicoltaurine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Carcinoma, Hepatocellular
×
Radiation
×
Clear all
NCT07027436
2025-06-18
DARTS
Hamilton Health Sciences Corporation
Phase 3
Not yet recruiting
30 enrolled